New method for turning genes on and off could enable more complex synthetic biology circuits

Sep 03, 2013 by Anne Trafton
Credit: CHRISTINE DANILOFF/IMOL

MIT researchers have shown that they can turn genes on or off inside yeast and human cells by controlling when DNA is copied into messenger RNA—an advance that could allow scientists to better understand the function of those genes.

The technique could also make it easier to engineer cells that can monitor their environment, produce a drug or detect disease, says Timothy Lu, an assistant professor of electrical engineering and and and the senior author of a paper describing the new approach in the journal ACS Synthetic Biology.

"I think it's going to make it a lot easier to build synthetic circuits," says Lu, a member of MIT's Synthetic Biology Center. "It should increase the scale and the speed at which we can build a variety of synthetic circuits in and mammalian cells."

The new method is based on a system of that have been exploited recently to edit the genomes of bacterial and . The original system, called CRISPR, consists of two components: a protein that binds to and slices DNA, and a short strand of RNA that guides the protein to the right location on the genome.

"The CRISPR system is quite powerful in that it can be targeted to different DNA binding regions based on simple recoding of these guide RNAs," Lu says. "By simply reprogramming the RNA sequence you can direct this protein to any location you want on the or on a synthetic circuit."

Lead author of the paper is Fahim Farzadfard, an MIT graduate student in biology. Samuel Perli, a graduate student in and computer science, is also an author.

Targeting transcription

In previous studies, CRISPR has been used to snip out pieces of a gene to disable it or replace it with a new gene. Lu and his colleagues decided to use the CRISPR system for a different purpose: controlling gene transcription, the process by which a sequence of DNA is copied into messenger RNA (mRNA), which carries out the gene's instructions.

Transcription is tightly regulated by proteins called transcription factors. These proteins bind to specific DNA sequences in the gene's promoter region and either recruit or block the enzymes needed to copy that gene into mRNA.

For this study, the researchers adapted the CRISPR system to act as a transcription factor. First, they modified the usual CRISPR protein, known as Cas9, so that it could no longer snip DNA after binding to it. They also added to the protein a segment that activates or represses gene expression by modulating the cell's transcriptional machinery.

To get Cas9 to the right place, the researchers also delivered to the target cells a gene for an RNA guide that corresponds to a DNA sequence on the promoter of the gene they want to activate.

The researchers showed that once the RNA guide and the Cas9 protein join together inside the target cell, they accurately target the correct gene and turn on transcription. To their surprise, they found that the same Cas9 complex could also be used to block if targeted to a different part of the gene.

"This is nice in that it allows you do to positive and negative regulation with the same protein, but with different guide RNAs targeted to different positions in the promoter," Lu says.

'A lot of flexibility'

The new system should be much easier to use than two other recently developed transcription-control systems based on DNA-binding proteins known as zinc fingers and transcription activator-like effector nucleases (TALENs), Lu says. Although they are effective, designing and assembling the proteins is time-consuming and expensive.

"There's a lot of flexibility with CRISPR, and it really comes from the fact that you don't have to spend any more time doing protein engineering. You can just change the nucleic acid sequence of the RNAs," Lu says.

"The fact that this can be used for efficient regulation of transcription in both yeast and mammalian cells is very encouraging," says Kobi Benenson, a professor of biosystems science and engineering at ETH Zurich, who was not part of the research team. "The technology can be used in the very near term for genetic engineering and applications—for biomanufacturing, tissue engineering and gene therapy, among other things."

The researchers also designed the transcription-control system so that it can be induced by certain small molecules that can be added to the cell, such as sugars. To do this, they engineered the for the guide RNAs so that they are only produced when the small molecule is present. Without the small molecule, there is no guide RNA and the targeted gene is undisturbed.

This type of control could be useful for studying the role of naturally occurring genes by turning them on and off at specific points during development or disease progression, Lu says.

Lu is now working on building more advanced synthetic circuits to perform applications such as making decisions based on several inputs from a cell's environment. "We'd like to be able to scale this up and demonstrate the most complex circuits that anyone's ever built in yeast and ," he says.

The paper is titled "Tunable and Multi-Functional Eukaryotic Transcription Factors Based on CRISPR/Cas."

Explore further: Novel approach to gene regulation can activate multiple genes simultaneously

Related Stories

Research update: Genome editing becomes more accurate

Jul 22, 2013

Earlier this year, MIT researchers developed a way to easily and efficiently edit the genomes of living cells. Now, the researchers have discovered key factors that influence the accuracy of the system, an ...

Researchers build a toolbox for synthetic biology

Aug 03, 2012

For about a dozen years, synthetic biologists have been working on ways to design genetic circuits to perform novel functions such as manufacturing new drugs, producing fuel or even programming the suicide ...

Enhancer RNAs may open new avenues for gene therapy

Aug 13, 2013

A study investigating the function of the recently discovered enhancer RNA molecules may open new avenues for gene therapy. According to the study researchers, altering the production and function of these ...

Recommended for you

New alfalfa variety resists ravenous local pest

13 hours ago

(Phys.org) —Cornell plant breeders have released a new alfalfa variety with some resistance against the alfalfa snout beetle, which has ravaged alfalfa fields in nine northern New York counties and across ...

New patenting guidelines are needed for biotechnology

Apr 22, 2014

Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper from Rice University's Baker Institute for Public Policy.

Rainbow trout genome sequenced

Apr 22, 2014

Using fish bred at Washington State University, an international team of researchers has mapped the genetic profile of the rainbow trout, a versatile salmonid whose relatively recent genetic history opens ...

User comments : 0

More news stories

Citizen scientists match research tool when counting sharks

Shark data collected by citizen scientists may be as reliable as data collected using automated tools, according to results published April 23, 2014, in the open access journal PLOS ONE by Gabriel Vianna from The University of Wes ...